1269618

Fenofibrate Related Compound B

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic acid, Fenofibric acid
• Empirical Formula (Hill Notation): C₁₇H₁₅ClO₄
• CAS Number: 42017-89-0
• Molecular Weight: 318.75
• Beilstein: 2058973
• MDL number: MFCD00792461
• UNSPSC Code: 41116107
• PubChem Substance ID: 329749839
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: fenofibrate
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: O=C(C1=CC=C(OC(C)(C)C(O)=O)C=C1)C2=CC=C(Cl)C=C2
• InChI: 1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)
• InChI key: MQOBSOSZFYZQOK-UHFFFAOYSA-N
• Gene Information: human ... PPARA(5465)

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Fenofibrate Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Fenofibrate
• Fenofibrate Capsules
• Fenofibrate Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Disclaimer

Sales restrictions may apply.

Safety Information

• Pictograms: GHS07,GHS09
• Signal Word: Warning
• Hazard Statements: H302,H410
• Precautionary Statements: P264 - P270 - P273 - P301 + P312 - P391 - P501
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3